Ср, 05/13/2015 - 10:05 — admin
 
 
 
 

_________________________________________________________
Hello and welcome to the latest edition of EMJ Urology, your trusted source for an abundance of cutting-edge, peer-reviewed research papers from some of the preeminent voices working in urology today. Once again, our staff have compiled a fascinating and insightful selection of articles in the hope of providing our readers with a timely, vital overview of the current state of urological medicine. This edition includes papers by Prof Jean de la Rosette and Prof Mark Emberton who, with Dr Caroline Charles, explore the promising perspectives offered by irreversible electroporation, a novel minimally invasive treatment option for prostate cancer patients, and Dr Marc Fourmarier, who reports on his institute’s experience using holmium laser enucleation of the prostate for the treatment of day-case patients.
 

However, the focal point of this volume will no doubt be our in-depth review of the recent European Association of Urology Congress 2015 (EAU), which took place in Madrid from 20th-24th March. We proudly present to you the comprehensive guide to this prestigious event, featuring detailed accounts of all of the key talking points, as well as reports on a host of innovative presentations and discussions direct from the show floor. In the interest of providing an exhaustive record of the weekend’s events, we have also included interviews with some of our editorial board members and a number of summaries of poster sessions presented at the congress. We trust that the content serves as a refresher for those fortunate enough to attend, or an indispensable resource for those unable to.

 

What's included in this edition of EMJ Urology?

 

Editorial Board

 

Congress Review
Review of the European Association of Urology Congress held in Madrid, Spain,
20th-24th March 2015

 

 

 Symposium Reviews

 

Abstract Reviews

Articles

 

Buyer’s Guide

Get Involved

 

We hope you enjoy reading this edition of EMJ Urology. It is our desire to provide you, our discerning reader, with an invaluable tool for research and discovery, and our ultimate goal is to develop the scientific knowledge and medical practice of physicians and researchers alike, in turn providing better treatment options and outcomes for patients. EMJ is also a platform for discussion, and to that end we have a strong presence on a multitude of social media platforms, so feel free to join the conversation on Facebook, Twitter and LinkedIn, as well as on our own website, which can be found here.

 

Warm regards,

 

Zoë Webster

Head of Publishing
 

_________________________________________________________

European Medical Journal 

 

Head Office – The MedBIC, Anglia Ruskin University, Alan Cherry Drive, Chelmsford, Essex, CM1 1SQ 

Sales Office - Coppergate House, 16 Brune Street, London, E1 7NJ

 

Switchboard: +44 (0) 1245 334450 

 

Visit Website

 

Registration No: 08198092. The information contained in this message is confidential and maybe legally privileged. It is intended for the addresses(s) only. Any unauthorised use, dissemination of the information, or unauthorised copying/forwarding of this message is prohibited. If you are not the intended addressee, please notify the sender immediately by return email and delete this message. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorised to state them.

_________________________________________________________

  

To ensure that you continue receiving our emails, please add us to your address book or safe list. If you are receiving this email continuously and if you think this is SPAM, please report to circulation@emjreviews.com and we will try our best to resolve your concerns. If you would like to Subscribe, please follow the link at the bottom through to our automated system, alternatively if you would like to Unsubscribe please also use the link provided.